CAMK2N1 itself has been reported as a prognostic marker for ovarian cancer45 and expression of which plays a tumour suppressive role in prostate cancer46 and glioma47, and in comparing all Pure DCIS with all other DCIS samples, is significantly down regulated in Not Pure DCIS samples (Fig. 6b). This evidence concerns the gene CAMK2N1 and neoplasm.